GlaxoSmithKline LLC et al v. Natco Pharma Ltd. et al
| GlaxoSmithKline LLC, TESARO, Inc. and Merck Sharp & Dohme LLC |
| Natco Pharma Ltd. and Natco Pharma USA LLC |
| 1:2026cv00168 |
| February 13, 2026 |
| U.S. District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 6, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 22 NOTICE requesting Clerk to remove Scott G. Greene as co-counsel.. (Silver, Daniel) |
Filing 21
SO ORDERED, re (47 in 1:25-cv-01170-CFC, 19 in 1:26-cv-00168-CFC) STIPULATION Regarding Case Consolidation and Amended Case Schedule filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. Signed by Judge Colm F. Connolly on 4/1/2026. Associated Cases: 1:25-cv-01170-CFC, 1:26-cv-00168-CFC (mws)
|
| Remark: The April 7, 2026 Rule 16 Scheduling Conference is cancelled. (mws) |
| Case associated with lead case: Create association to 1:25-cv-01170-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 25-1170-CFC ONLY. (mws) |
| Filing 20 Letter to Chief Judge Connolly from Alexandra M. Joyce regarding Joint Request to Remove April 7, 2026 Rule 16 Conference from the Courts Calendar. (Joyce, Alexandra) |
|
Filing 19
STIPULATION and Order Regarding Case Consolidation and Amended Case Schedule - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Joyce, Alexandra)
|
| Pro Hac Vice Attorney River E. Lord, Joanna Garelick Goldstein,Christopher J. Sorenson, Jason M. Wiener for Natco Pharma Ltd., Natco Pharma USA LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lah) |
| Filing 18 Pro Hac Vice Fee - Credit Card Payment received for Christopher J. Sorenson, River Lord, Jason M. Wiener, Joanna Garelick Goldstein, and Andrew O. Larsen, Ph.D.. ( re #17 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, River Lord, Jason M. Wiener, Joanna Garelick Goldstein and Andrew O. Larsen, Ph.D. )( Payment of $ 250, receipt number ADEDC-4932661).(Pedi, Nicole) |
| Filing 17 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, River Lord, Jason M. Wiener, Joanna Garelick Goldstein and Andrew O. Larsen, Ph.D. - filed by Natco Pharma Ltd., Natco Pharma USA LLC. (Pedi, Nicole) |
|
SO ORDERED, re #17 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, River Lord, Jason M. Wiener, Joanna Garelick Goldstein and Andrew O. Larsen, Ph.D., filed by Natco Pharma Ltd., Natco Pharma USA LLC. Ordered by Judge Colm F. Connolly on 3/26/2026. (kmd)
|
| Pro Hac Vice Attorney Timothy A. Cook, Christopher M. Cherry, Christopher R. Noyes, Anna Wong & Reshma C. Gogineni for GlaxoSmithKline LLC, Merck Sharp & Dohme LLC & TESARO, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk) |
| Filing 16 Pro Hac Vice Fee - Credit Card Payment received for Anna Wong. ( re #14 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong )( Payment of $ 50, receipt number ADEDC-4929464).(Silver, Daniel) |
| Filing 15 Pro Hac Vice Fee - Credit Card Payment received for Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, and Christopher M. Cherry. ( re #14 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong )( Payment of $ 250, receipt number ADEDC-4929456).(Silver, Daniel) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Attachments: #1 Certifications for Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong)(Silver, Daniel) |
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Timothy A. Cook, Scott G. Greene, Reshma C. Gogineni, Christopher M. Cherry, and Anna Wong, filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. Ordered by Judge Colm F. Connolly on 3/23/2026. (kmd)
|
|
Filing 13
Order Setting Telephonic Scheduling Conference: A Telephonic Scheduling Conference is set for 4/7/2026 at 09:00 AM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 3/9/2026. (mws)
|
| Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent No Corporate Parent for Natco Pharma Ltd.; Corporate Parent Natco Pharma Ltd. for Natco Pharma USA LLC filed by Natco Pharma Ltd., Natco Pharma USA LLC. (Pedi, Nicole) |
| Filing 11 ANSWER to #1 Complaint, and Affirmative Defenses by Natco Pharma Ltd., Natco Pharma USA LLC.(Cragg, Tyler) |
| Filing 10 DECLARATION of Service for Natco Pharma Ltd. by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Joyce, Alexandra) |
| Filing 9 SUMMONS Returned Executed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc..Natco Pharma USA LLC served on 2/17/2026, answer due 3/10/2026. (Silver, Daniel) |
| Filing 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (alb) |
| Filing 7 Summons Issued as to Natco Pharma Ltd. on 2/17/2026; Natco Pharma USA LLC on 2/17/2026. (Attachments: #1 Summons Issued)(mrr) |
| CORRECTING ENTRY: The stay deadline at D.I. #3 has been corrected. (nms) |
| Filing 6 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,091,459; 11,673,877. (mrr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme LLC filed by Merck Sharp & Dohme LLC. (mrr) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent GSK plc for GlaxoSmithKline LLC; Corporate Parent GlaxoSmithKline LLC, Other Affiliate GSK plc for TESARO, Inc. filed by GlaxoSmithKline LLC, TESARO, Inc. (mrr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/9/2026. Date of Expiration of Patent: 11,091,459, Expiration date: 3/27/2038 & 11,673,877 Date of Expiration: 3/27/2038.Thirty Month Stay Deadline: No earlier than 7/9/2028. (mrr) Modified on 2/17/2026 (nms). |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) |
| Filing 1 COMPLAINT for Patent Infringement against Natco Pharma Ltd., Natco Pharma USA LLC (Filing fee $ 405, receipt number ADEDC-4900762) - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. (Attachments: #1 Exhibits A-B, #2 Civil Cover Sheet)(mrr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
